12,123 followers
RT @RnaseqS: Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development: CONCLUSION: TP53, IDH1, C…
RT @RnaseqS: Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development: CONCLUSION: TP53, IDH1, C…
Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development: CONCLUSION: TP53, IDH1, C3, and TCF12 are effective antigens for the development of anti-glioma mRNA vaccines. We found four stable and repeatable immune…